Efficacy of Inpatient, Evidence-Based Tobacco Use Treatment of Patients With Bladder Cancer After Radical Cystectomy

IF 2.3 3区 医学 Q3 ONCOLOGY Clinical genitourinary cancer Pub Date : 2024-10-28 DOI:10.1016/j.clgc.2024.102252
Hersh Trivedi , Hannah Kay , Katy Reines , Julie Hartzell , Eiman Newcomer , Shannon Myers , Richard S. Matulewicz , Adam O. Goldstein , Kimberly A. Shoenbill , Marc A. Bjurlin
{"title":"Efficacy of Inpatient, Evidence-Based Tobacco Use Treatment of Patients With Bladder Cancer After Radical Cystectomy","authors":"Hersh Trivedi ,&nbsp;Hannah Kay ,&nbsp;Katy Reines ,&nbsp;Julie Hartzell ,&nbsp;Eiman Newcomer ,&nbsp;Shannon Myers ,&nbsp;Richard S. Matulewicz ,&nbsp;Adam O. Goldstein ,&nbsp;Kimberly A. Shoenbill ,&nbsp;Marc A. Bjurlin","doi":"10.1016/j.clgc.2024.102252","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Despite a 3-fold increase in risks of bladder cancer (BC) among current smokers, smoking cessation therapy for patients undergoing treatment is significantly underutilized. Inpatient admission after surgery provides a teachable moment to pursue tobacco treatment. We conducted a 12-month prospective quality improvement initiative to increase tobacco treatment program (TTP) consultations with BC patients who smoke and underwent radical cystectomy (RC).</div></div><div><h3>Materials and Methods</h3><div>From 6/2022 to 6/2023, patients admitted after RC for BC who were identified to be current smokers were referred to our institution's inpatient TTP. A baseline standardized assessment of tobacco dependence was conducted postoperatively, and nicotine replacement therapy (NRT) was prescribed both inpatient and upon discharge. Study endpoints included the percentage of patients receiving inpatient TTP consultation, inpatient and 1-month NRT prescription fill rates, tobacco usage, cessation rates, quit attempts, and patient and provider satisfaction. Postintervention outcomes were compared to historical controls.</div></div><div><h3>Results</h3><div>Of the 16 inpatients (of 63 RCs) who smoked and received a TTP referral, 15 accepted. Referrals to TTP increased from 20% at baseline to 100% after implementation of the intervention (<em>P</em> = .01). NRT was prescribed for 40% of inpatients, and 60% of patients filled NRT after discharge. At 1-month follow-up, a significant decrease occurred in cigarette use (12.6 cigarettes/day to 6.8 cigarettes/day; <em>P</em> = .001). The majority, 86%, reported attempts to quit, and 29% reported that they successfully quit smoking. Patients reported high levels of stress reduction, confidence to quit, desire to quit, and willingness to use NRT. Most (83%) providers were very satisfied with the TTP and felt recommendations were easy to implement.</div></div><div><h3>Conclusions</h3><div>This study successfully increased the use of inpatient TTP in patients with BC who smoked and were undergoing RC. The positive outcomes, including high acceptability among patients, increased rates of TTP consultations, reduced cigarette usage postintervention, and notable satisfaction among healthcare providers, suggest that these strategies can be readily adopted by urologic care teams.</div></div>","PeriodicalId":10380,"journal":{"name":"Clinical genitourinary cancer","volume":"23 1","pages":"Article 102252"},"PeriodicalIF":2.3000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical genitourinary cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1558767324002222","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Despite a 3-fold increase in risks of bladder cancer (BC) among current smokers, smoking cessation therapy for patients undergoing treatment is significantly underutilized. Inpatient admission after surgery provides a teachable moment to pursue tobacco treatment. We conducted a 12-month prospective quality improvement initiative to increase tobacco treatment program (TTP) consultations with BC patients who smoke and underwent radical cystectomy (RC).

Materials and Methods

From 6/2022 to 6/2023, patients admitted after RC for BC who were identified to be current smokers were referred to our institution's inpatient TTP. A baseline standardized assessment of tobacco dependence was conducted postoperatively, and nicotine replacement therapy (NRT) was prescribed both inpatient and upon discharge. Study endpoints included the percentage of patients receiving inpatient TTP consultation, inpatient and 1-month NRT prescription fill rates, tobacco usage, cessation rates, quit attempts, and patient and provider satisfaction. Postintervention outcomes were compared to historical controls.

Results

Of the 16 inpatients (of 63 RCs) who smoked and received a TTP referral, 15 accepted. Referrals to TTP increased from 20% at baseline to 100% after implementation of the intervention (P = .01). NRT was prescribed for 40% of inpatients, and 60% of patients filled NRT after discharge. At 1-month follow-up, a significant decrease occurred in cigarette use (12.6 cigarettes/day to 6.8 cigarettes/day; P = .001). The majority, 86%, reported attempts to quit, and 29% reported that they successfully quit smoking. Patients reported high levels of stress reduction, confidence to quit, desire to quit, and willingness to use NRT. Most (83%) providers were very satisfied with the TTP and felt recommendations were easy to implement.

Conclusions

This study successfully increased the use of inpatient TTP in patients with BC who smoked and were undergoing RC. The positive outcomes, including high acceptability among patients, increased rates of TTP consultations, reduced cigarette usage postintervention, and notable satisfaction among healthcare providers, suggest that these strategies can be readily adopted by urologic care teams.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
膀胱癌根治术后住院患者烟草使用循证治疗的疗效。
目的:尽管当前吸烟者罹患膀胱癌(BC)的风险增加了 3 倍,但正在接受治疗的患者的戒烟治疗却严重不足。手术后的住院病人是进行戒烟治疗的最佳时机。我们开展了一项为期12个月的前瞻性质量改进计划,以增加接受根治性膀胱切除术(RC)的吸烟膀胱癌患者的烟草治疗计划(TTP)咨询:从2022年6月至2023年6月,接受根治性膀胱切除术(RC)后入院的BC患者中被确认为吸烟者的患者被转诊至本机构的住院TTP。术后进行了烟草依赖基线标准化评估,并在住院和出院时处方尼古丁替代疗法(NRT)。研究终点包括接受住院TTP咨询的患者比例、住院和1个月的NRT处方开具率、烟草使用率、戒烟率、戒烟尝试以及患者和医疗服务提供者的满意度。干预后的结果与历史对照进行了比较:在接受TTP转介的16名吸烟住院患者(63名RC)中,15人接受了TTP转介。实施干预后,转诊到TTP的患者从基线的20%增加到100%(P = .01)。40%的住院患者获得了非戒烟治疗处方,60%的患者在出院后服用了非戒烟治疗药物。在 1 个月的随访中,吸烟量明显减少(从每天 12.6 支减少到每天 6.8 支;P = .001)。大多数患者(86%)表示尝试过戒烟,29%的患者表示成功戒烟。患者在减轻压力、戒烟信心、戒烟愿望和使用 NRT 的意愿方面都有很高的水平。大多数(83%)医疗服务提供者对TTP非常满意,并认为建议易于实施:这项研究成功地提高了住院TTP在吸烟并接受RC治疗的BC患者中的使用率。积极的结果,包括患者的高接受度、TTP咨询率的提高、干预后香烟使用量的减少以及医疗服务提供者的显著满意度,都表明这些策略可以被泌尿科护理团队轻松采用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical genitourinary cancer
Clinical genitourinary cancer 医学-泌尿学与肾脏学
CiteScore
5.20
自引率
6.20%
发文量
201
审稿时长
54 days
期刊介绍: Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
期刊最新文献
ALK-Rearranged Renal Cell Carcinoma: A Study of Three Cases With Clinicopathologic Features and Effect of Postoperative Adjuvant Immunotherapy Prospective Study of Patient, Nursing, and Oncology Provider Perspectives on Telemedicine Visits for Renal Cell Carcinoma Clinical Trials Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study Letter to the Editor: Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1